← Leaderboards
Wei Zheng
National Center For Advancing Translational Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Center For Advancing Translational Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Drug Discovery”
- David Heimbrook · Leidos Biomedical Research, Inc.$369,513,553
- Leonard Freedman · Leidos Biomedical Research, Inc.$255,277,443
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ralph Parchment · Leidos Biomedical Research, Inc.$137,717,670
- Daniel Ernest Ford · Johns Hopkins University$137,014,543
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
Research focus
Drug DiscoveryScreeningCellsPharmaceutical PreparationsNovel TherapeuticsAnimal ModelCostClinical TrialsClinical TreatmentClinical DataIn Vitro AssayDrug DevelopmentPre-ClinicalResearch PersonnelUniversitiesLibrariesUnited States National Institutes Of HealthHigh Throughput ScreeningDisease ModelInduced Pluripotent Stem CellCommunicable DiseasesNovel StrategiesDisease PhenotypeNerve Stem Cell
Grant awards (19)
Drug Repurposing Screening for Rare and Neglected Diseases$755,501
ZIA · FY2025 · TR · contact PI
Disease Modeling Using Patient iPS Cell-Derived Cells and Organoids$297,261
ZIA · FY2025 · TR · contact PI
AI-Based Modeling and Drug Development$222,049
ZIA · FY2025 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$2,200,000
ZIA · FY2024 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$2,859,284
ZIA · FY2023 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$3,765,980
ZIA · FY2022 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$2,156,297
ZIA · FY2021 · TR · contact PI
Drug Repurposing Screening for Zika Virus Infection$1,600,138
ZIA · FY2021 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$3,564,200
ZIA · FY2020 · TR · contact PI
Drug Repurposing Screening for Zika Virus Infection$999,652
ZIA · FY2020 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$2,908,150
ZIA · FY2019 · TR · contact PI
Drug Repurposing Screening for Zika Virus Infection$901,090
ZIA · FY2019 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$2,167,870
ZIA · FY2018 · TR · contact PI
Drug Repurposing Screening for Zika Virus Infection$872,090
ZIA · FY2018 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$1,657,697
ZIA · FY2017 · TR · contact PI
Drug Repurposing Screening for Zika Virus Infection$759,021
ZIA · FY2017 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$1,292,761
ZIA · FY2016 · TR · contact PI
Drug Repurposing Screening for Zika Virus Infection$994,436
ZIA · FY2016 · TR · contact PI
Drug Repurposing Screening for Rare and Neglected Diseases$1,300,000
ZIA · FY2015 · TR · contact PI